Oscar Health, Inc. (NYSE:OSCR) Given Average Rating of "Reduce" by Brokerages

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has been given a consensus recommendation of "Reduce" by the seven research firms that are presently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $16.58.

A number of research firms have commented on OSCR. Raymond James Financial lowered shares of Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Piper Sandler reduced their price objective on shares of Oscar Health from $25.00 to $18.00 and set an "overweight" rating on the stock in a research note on Monday, June 9th. Wall Street Zen cut shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Sunday, June 8th. Wells Fargo & Company lowered Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Finally, Barclays began coverage on shares of Oscar Health in a report on Wednesday, July 2nd. They issued an "underweight" rating and a $17.00 price target for the company.

Oscar Health Price Performance

OSCR traded up $0.32 during trading on Friday, hitting $16.79. The company's stock had a trading volume of 32,496,161 shares, compared to its average volume of 6,381,160. The firm's 50 day moving average price is $16.02 and its two-hundred day moving average price is $14.82. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22. Oscar Health has a 12 month low of $11.20 and a 12 month high of $23.79. The stock has a market capitalization of $4.28 billion, a price-to-earnings ratio of 59.96 and a beta of 1.90.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. Oscar Health's revenue was up 42.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.62 EPS. Sell-side analysts forecast that Oscar Health will post 0.69 earnings per share for the current fiscal year.

Insider Transactions at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the sale, the director directly owned 64,512 shares in the company, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 24.39% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Rhumbline Advisers boosted its holdings in shares of Oscar Health by 6.0% during the 1st quarter. Rhumbline Advisers now owns 287,458 shares of the company's stock worth $3,769,000 after buying an additional 16,231 shares during the period. Strs Ohio bought a new position in Oscar Health during the 1st quarter worth $30,000. Intech Investment Management LLC boosted its position in shares of Oscar Health by 50.3% in the first quarter. Intech Investment Management LLC now owns 139,600 shares of the company's stock valued at $1,830,000 after acquiring an additional 46,748 shares during the period. Focus Partners Wealth raised its stake in Oscar Health by 1.8% in the 1st quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock worth $723,000 after purchasing an additional 949 shares in the last quarter. Finally, SCS Capital Management LLC bought a new stake in shares of Oscar Health in the first quarter valued at approximately $131,000. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.